Literature DB >> 12637245

Non-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effects.

K Maekawa1, M Itoda, N Hanioka, Y Saito, N Murayama, O Nakajima, A Soyama, S Ishida, S Ozawa, M Ando, J Sawada.   

Abstract

1. By sequencing genomic DNA from 72 established cell lines derived from Japanese individuals, we detected 25 single nucleotide alterations in the microsomal epoxide hydrolase (EPHX1) gene. Of them, five were exonic alterations resulting in amino acid alterations (77C>G, T26S; 128G>C, R43T; 337T>C, Y113H; 416A>G, H139R; 823A>G, T275A). The T26S, R43T, Y113H and H139R substitutions were found at relatively high frequencies and seemed to be polymorphic, and T26S and T275A were novel. 2. To examine the effects of these amino acid alterations on EPHX1 function, EPHX1 cDNA constructs of wild-type and five variants were transfected into COS-1 cells, and their hydrolytic activities for cis-stilbene oxide were determined in vitro. Although all of the transfectants expressed EPHX1 mRNA and protein at similar levels, the variant H139R protein was expressed at a significantly higher level (128% of the wild-type). K(m) values were not significantly different between the wild-type and variants. 3. Increase (140%) in the enzymatic activity (V(max)) of the variant H139R was accompanied by the increased EPHX1 protein level without any significant change in the intrinsic EPHX1 activity. On the other hand, the variant R43T showed increased values for V(max) and clearance (V(max)/K(m)) (around 130%) both on a microsomal protein basis and on a EPHX1 protein basis. 4. These results suggest that R43T as well as H139R increase epoxide hydrolase activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637245     DOI: 10.1080/0049825021000061615

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  8 in total

1.  Development of monoclonal antibodies to human microsomal epoxide hydrolase and analysis of "preneoplastic antigen"-like molecules.

Authors:  Hongying Duan; Kazunori Yoshimura; Nobuharu Kobayashi; Kazuo Sugiyama; Jun-Ichi Sawada; Yoshiro Saito; Christophe Morisseau; Bruce D Hammock; Toshitaka Akatsuka
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-28       Impact factor: 4.219

2.  Functional analysis of human microsomal epoxide hydrolase genetic variants.

Authors:  Vinayak P Hosagrahara; Allan E Rettie; Christopher Hassett; Curtis J Omiecinski
Journal:  Chem Biol Interact       Date:  2004-11-20       Impact factor: 5.192

3.  Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A.

Authors:  Toshitaka Akatsuka; Nobuharu Kobayashi; Takashi Ishikawa; Takafumi Saito; Michiko Shindo; Masayoshi Yamauchi; Kazutaka Kurokohchi; Hitoshi Miyazawa; Hongying Duan; Toshiyuki Matsunaga; Tsugikazu Komoda; Christophe Morisseau; Bruce D Hammock
Journal:  J Autoimmun       Date:  2007-02-12       Impact factor: 7.094

4.  Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.

Authors:  Yukiko Nakajima; Yoshiro Saito; Kisho Shiseki; Hiromi Fukushima-Uesaka; Ryuichi Hasegawa; Shogo Ozawa; Kenji Sugai; Masaaki Katoh; Osamu Saitoh; Teiichi Ohnuma; Mitsuru Kawai; Taisuke Ohtsuki; Chieko Suzuki; Narihiro Minami; Hideo Kimura; Yu-ichi Goto; Naoyuki Kamatani; Nahoko Kaniwa; Jun-ichi Sawada
Journal:  Eur J Clin Pharmacol       Date:  2005-02-04       Impact factor: 2.953

5.  Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.

Authors:  Jian-Qing Zhang; Jia-Qiang Zhang; Hua Liu; Zhi-Huan Zhao; Li-Zhou Fang; Ling Liu; Wei-Ping Fu; Jing-Kui Shu; Jia-Gang Feng; Lu-Ming Dai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-13

6.  Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: A comprehensive meta-analysis.

Authors:  Hui Li; Wei-Ping Fu; Ze-Hui Hong
Journal:  Oncol Lett       Date:  2012-12-28       Impact factor: 2.967

7.  Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.

Authors:  Armond Daci; Giangiacomo Beretta; Driton Vllasaliu; Aida Shala; Valbona Govori; Giuseppe Danilo Norata; Shaip Krasniqi
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

8.  Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.

Authors:  Gwendolin S Simper; Gia-Gia T Hò; Alexander A Celik; Trevor Huyton; Joachim Kuhn; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  J Immunol Res       Date:  2018-09-13       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.